Neumann Elena, Rudolph Uwe, Knutson Daniel E, Li Guanguan, Cook James M, Hentschke Harald, Antkowiak Bernd, Drexler Berthold
Experimental Anesthesiology Section, Department of Anesthesiology and Intensive Care, Eberhard Karls Universität Tübingen, Tübingen, Germany.
Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, United States.
Front Pharmacol. 2019 Jan 9;9:1523. doi: 10.3389/fphar.2018.01523. eCollection 2018.
High frequency neuronal activity in the cerebral cortex can be induced by noxious stimulation during surgery, brain injury or poisoning. In this scenario, it is essential to block cortical hyperactivity to protect the brain against damage, e.g., by using drugs that act as positive allosteric modulators at GABA receptors. Yet, cortical neurons express multiple, functionally distinct GABA receptor subtypes. Currently there is a lack of knowledge which GABA receptor subtypes would be a good pharmacological target to reduce extensive cortical activity. Spontaneous action potential activity was monitored by performing extracellular recordings from organotypic neocortical slice cultures of wild type and GABAR-α1(H101R) mutant mice. Phases of high neuronal activity were characterized using peri-event time histograms. Drug effects on within-up state firing rates were quantified via Hedges' g. We quantified the effects of zolpidem, a positive modulator of GABA receptors harboring α1-subunits, and the experimental benzodiazepine SH-053-2'F-S-CH3, which preferably acts at α2/3/5- but spares α1-subunits. Both agents decreased spontaneous action potential activity but altered the firing patterns in different ways. Zolpidem reduced action potential firing during highly active network states. This action was abolished by flumazenil, suggesting that it was mediated by benzodiazepine-sensitive GABA receptors. SH-053-2'F-S-CH3 also attenuated neuronal activity, but unlike zolpidem, failed to reduce high frequency firing. To confirm that zolpidem actions were indeed mediated via α1-dependent actions, it was evaluated in slices from wild type and α(H101R) knock-in mice. Inhibition of high frequency action potential firing was observed in slices from wild type but not mutant mice. Our results suggest that during episodes of scarce and high neuronal activity action potential firing of cortical neurons is controlled by different GABA receptor subtypes. Exaggerated firing of cortical neurons is reduced by positive modulation of α1-, but not α2/3/5-subunit containing GABA receptors.
在手术、脑损伤或中毒期间,有害刺激可诱发大脑皮层的高频神经元活动。在这种情况下,通过使用作为GABA受体正变构调节剂的药物来阻断皮层过度活动以保护大脑免受损伤至关重要。然而,皮层神经元表达多种功能不同的GABA受体亚型。目前尚不清楚哪种GABA受体亚型是减少广泛皮层活动的良好药理学靶点。通过对野生型和GABAR-α1(H101R)突变小鼠的器官型新皮层切片培养物进行细胞外记录来监测自发动作电位活动。使用事件周围时间直方图来表征高神经元活动阶段。通过Hedges' g对药物对向上状态放电率的影响进行量化。我们量化了唑吡坦(一种含有α1亚基的GABA受体的正调节剂)和实验性苯二氮䓬SH-053-2'F-S-CH3的作用,后者优先作用于α2/3/5亚基,但不作用于α1亚基。两种药物均降低了自发动作电位活动,但以不同方式改变了放电模式。唑吡坦在高度活跃的网络状态下减少动作电位发放。氟马西尼可消除此作用,表明它是由苯二氮䓬敏感的GABA受体介导的。SH-053-2'F-S-CH3也减弱了神经元活动,但与唑吡坦不同,它未能降低高频发放。为了证实唑吡坦的作用确实是通过α1依赖性作用介导的,在野生型和α(H101R)基因敲入小鼠的切片中对其进行了评估。在野生型小鼠的切片中观察到高频动作电位发放受到抑制,而在突变小鼠中未观察到。我们的结果表明,在神经元活动稀少且高度活跃的时期,皮层神经元的动作电位发放受不同的GABA受体亚型控制。通过对含有α1亚基而非α2/3/5亚基的GABA受体进行正调节,可减少皮层神经元的过度发放。